ClinicalTrials.gg
CompletedNCT04089137Updated Feb 5, 2025Results posted

Alcohol and Violence Prevention for College Students

An interventional study of Positive Change (+Change) in Alcohol Drinking and Sexual Assault, sponsored by Georgia State University. Completed at 2 sites in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-05.

Sponsored by Georgia State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Mar 2018, registered Aug 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Heavy episodic drinking and sexual assault (SA) are problematic on college campuses. This project will adapt already developed interventions targeting alcohol use and SA to a mHealth format and involve content that incorporates federal guidelines and CDC recommendations to integrate both bystander intervention and risk reduction content with new innovative personalized content for each risk group (cis-gender heterosexual men, cis-gender heterosexual women, and sexual/gender minorities). Alpha testing with key stakeholders, an open pilot trial, and a randomized pilot trial will be conducted to establish acceptability and to estimate sample size for a larger randomized controlled trial.

Read the detailed description

Specific aims are as follows:

Aim 1 (Stage IA): Modify Alcohol and Sexual Assault Prevention (ASAP) content to an eHealth format to include personalized content for each risk group (1. cisgender heterosexual men; 2. cisgender heterosexual women; and 3. sexual and gender minorities).

Aim 1a: Assess normative behaviors (n = 500) regarding alcohol use and SA for feedback.

Aim 1b: Adapt and assess initial acceptability of a workbook version of the intervention content among key stakeholders (college administrators and students from each risk group [n=5 from each group]).

Aim 2 (Stage IB): Open Pilot Trial. Obtain usability of ASAP among 30 students who engage in HED (10 from each risk group) in an open pilot trial.

Aim 3 (Stage IB): A pilot to assess effect size and variability for planning a randomized trial in the future. Randomize students who engage in HED to ASAP or control condition to observe preliminary effect sizes and estimate the variability using a 3-month follow-up. Sample size was determined to estimate the variability within a reasonable margin of error. This calculation also accounted the low base rates of SA and 20% attrition. This led to a sample size of 162 students (n=54 from each risk group).

02

Conditions studied

  • Alcohol Drinking
  • Sexual Assault

Browse trials for

03

In context

Alcohol Drinking

701 studies on the registry are indexed under Alcohol Drinking; 133 are open to participants now.

This study's enrollment of 165 is above the median of 122 across 607 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

Georgia State University is the lead sponsor of 56 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-25 years old
  • Current student at university of study
  • Valid email address at university of study
  • Endorse engaging in heavy episodic drinking at least once in the past month on the screening survey

Exclusion criteria

Exclusion Criteria:

  • There are no exclusion criteria other than not meeting inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
165 participants (actual)

Study arms

  • No intervention
    Control

    This is an assessment only control condition.

  • Experimental
    Positive Change (+Change)

    This is an integrated social norms-based personalized feedback intervention for college students targeting alcohol misuse and sexual assault. This intervention targets alcohol use, sexual assault victimization risk, sexual assault perpetration, and bystander intervention and is tailored by gender and sexual orientation.

    Behavioral: Positive Change (+Change)

Interventions

  • BehavioralPositive Change (+Change)

    This is an integrated social norms-based personalized feedback intervention for college students targeting alcohol misuse and sexual assault. This intervention targets alcohol use, sexual assault victimization risk, sexual assault perpetration, and bystander intervention and is tailored by gender and sexual orientation.

06

What researchers measure

Primary outcomes

  1. Feasibility of Enrollment and Recruitment

    Feasibility of enrollment recruitment was assessed by the number of anticipated participants enrolled in the study

    Time frame: within 2 year recruitment period

  2. Feasibility of Retention

    Feasibility of retention was assessed by the number of participants retained in the study

    Time frame: within 3 months of baseline participation

07

Results

Posted Feb 5, 2025

Participant flow

Participant flow — Overall Study
MilestoneControlPositive Change (+Change)
Started8283
Completed8283
Not completed00

Outcome measures

PrimaryFeasibility of Enrollment and Recruitment

Feasibility of enrollment recruitment was assessed by the number of anticipated participants enrolled in the study

Time frame:
within 2 year recruitment period
Reported as:
Count of participants · Participants
Feasibility of Enrollment and Recruitment
ParticipantsControlPositive Change (+Change)
Feasibility of Enrollment and Recruitment8283
PrimaryFeasibility of Retention

Feasibility of retention was assessed by the number of participants retained in the study

Time frame:
within 3 months of baseline participation
Reported as:
Count of participants · Participants
Feasibility of Retention
ParticipantsControlPositive Change (+Change)
Feasibility of Retention7170

Adverse events

Collected over Adverse events were monitored throughout the 3-month data were collection period.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control0/82 (0%)0/82 (0%)0/82 (0%)
Positive Change (+Change)0/83 (0%)0/83 (0%)0/83 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)ControlPositive Change (+Change)Total
Mean20.5 ± 1.5920.2 ± 1.6620.35 ± 1.62
Sex/Gender, Customized
Sex/Gender, Customized(Participants)ControlPositive Change (+Change)Total
Cisgender heterosexual woman272754
Cisgender heterosexual man292857
Sexual or gender minority262854
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)ControlPositive Change (+Change)Total
Hispanic or Latino242145
Not Hispanic or Latino5860118
Unknown or Not Reported022
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)ControlPositive Change (+Change)Total
American Indian/Alaska Native123
Asian6713
Black or African American123
White6358121
More than One Race549
Other5611
Prefer not to Answer145
Region of Enrollment
Region of Enrollment(Participants)ControlPositive Change (+Change)Total
United States8283165
Enrolled in the study before the COVID-19 pandemic
Enrolled in the study before the COVID-19 pandemic(Participants)ControlPositive Change (+Change)Total
Count of participants384987
08

Study locations

2 sites
  • Arizona State University
    Tempe, Arizona 85281, United States
  • Georgia State University
    Atlanta, Georgia 30303, United States
09

References and documents

Publications

  • Gilmore AK, Leone RM, Oesterle DW, Davis KC, Orchowski LM, Ramakrishnan V, Kaysen D. Web-Based Alcohol and Sexual Assault Prevention Program With Tailored Content Based on Gender and Sexual Orientation: Preliminary Outcomes and Usability Study of Positive Change (+Change). JMIR Form Res. 2022 Jul 22;6(7):e23823. doi: 10.2196/23823. PubMed 35867393 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — No sharing of individual participant data, only de-identified data.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Sep 2021, 41 months.

Results were first posted in Feb 2025, 3 years 4 months after primary completion.

Of 328 non-industry interventional studies with no phase under Alcohol Drinking, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 41 months is above that.

Counting every sponsor, half of 336 studies reached it within 24 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2019
First posted
Sep 13, 2019
StartActual
Mar 15, 2018
Primary completionActual
Sep 8, 2021
CompletionActual
Sep 8, 2021
Results first posted
Feb 5, 2025
Last update
Feb 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04089137
Lead sponsor
Georgia State University
Responsible party
Amanda Gilmore (Assistant Professor, Mark Chaffin Center for Healthy Development and Department of Health Policy and Behavioral Sciences, School of Public Health, Georgia State University) — Principal investigator
First posted
Sep 13, 2019
Start date
Mar 15, 2018
Primary completion
Sep 8, 2021
Completion
Sep 8, 2021
Results posted
Feb 5, 2025
Last update
Feb 5, 2025

Study contacts

Amanda K Gilmore, PhD
principal investigator · Georgia State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion